Fourier ExoMotus M4

Powered bilateral lower-limb rehabilitation exoskeleton with motorized hip/knee actuators and AI-adaptive passive/assistive/active/resistive modes selectable by patient stage. Commercial (clinical, Asia-Pacific focus). (Distinct from Fourier's GR humanoid line.)

Yes. Fourier ExoMotus M4 is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Fourier ExoMotus M4 is made by Fourier Intelligence, based in Shanghai, China, founded in 2015.

2 verified deployments of Fourier ExoMotus M4 are on the DEPLOY registry, including at China, Asia, United States (multiple hotel chains).

Fourier ExoMotus M4 is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable exoskeleton robots to Fourier ExoMotus M4 include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.

Fourier ExoMotus M4 and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Fourier ExoMotus M4 has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Fourier ExoMotus M4 ranks in roughly the top 23% of exoskeleton models tracked by the registry.

Fourier ExoMotus M4 is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Fourier ExoMotus M4 has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.